ArticleNature communications2025
A planar chiral organoselenium enabled enantioselective intramolecular oxidation of trisubstituted olefins.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Copper-Catalyzed Enantioselective Synthesis of Chiral Selenium-Based Versatile Synthons.ACS central science · 2026Article
- Selenium-catalyzed organic transformations.iScience · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Electrophilic selenium catalysis has recently emerged as an attractive synthetic strategy, yet the field of enantioselective electrophilic selenium catalysis remains underdeveloped, primarily due to the scarcity of efficient chiral catalysts and limited reaction types. Herein, we disclose the design and synthesis of a series of planar chiral organoseleniums based on [2.2]paracyclophane. With these chiral organoseleniums as catalysts, we accomplish a highly enantioselective intramolecular oxidative etherification of trisubstituted olefins, providing a diverse array of optically pure chromans bearing a quaternary carbon stereocenter. The stereochemical versatility of this method enables efficient access to both product enantiomers from the same catalyst by adjusting the E/Z configurations of the olefins. Importantly, comprehensive control experiments and kinetic studies elucidate the reaction mechanism, identifying the oxidation of selenenylated cyclic ether as the likely turnover-limiting step. DFT calculations demonstrate that both steric hindrance and weak interactions play a vital role in enantioselectivity.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.